drugset / Trial / NCT01387347
Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Thymosin Beta 4 (Tβ4) is a synthetic copy of the naturally-occurring 43-amino acid peptide that is found in a variety of tissues. Tβ4 promotes/accelerates wound repair in dermal, ocular, and cardiac animal models. Two recent pre-clinical evaluations have demonstrated that Tβ4 promotes corneal ocular surface defects healing in animal models of dry eye. RGN-259 (formulation of Tβ4 ophthalmic solution) mechanism of action offers potential to be a product that meets a major unmet medical need in patients with dry eye.
Timeline
- Start
- 2011-08
- Primary completion
- 2011-10
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Thymosin Beta 4 | Peptide | 0.1 % | Topical |